The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients with Major Depressive Disorder (MDD)
Monday, September 19, 2022
12:00 PM – 1:15 PM CT
Location: Room 255
Lunch will be served. Seating is limited to 200 attendees and will be available on a first-come, first-served basis. Please plan to arrive early to ensure a seat. No CE credits are offered at these programs.
Presenter(s): Gerald A. Maguire, MD, DFAPA Professor and Chair Psychiatry and Neuroscience University of California, Riverside School of Medicine Riverside, California
This presentation is provided by Otsuka America Pharmaceutical, Inc. and Lundbeck.